HEPA
Hepion Pharmaceuticals, Inc.NASDAQHealthcare$0.06+0.00%ClosedMarket Cap: $639,117
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.19
P/S
0.00
EV/EBITDA
0.14
DCF Value
$0.17
FCF Yield
-511.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-242.0%
ROA
-269.6%
ROIC
-147.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-609.7K | $-656.9K | $1.40 | — |
| FY 2025 | $0.00 | NaN% | $-4.2M | $-8.3M | $-0.88 | — |
| Q3 2025 | $0.00 | NaN% | $-527.9K | $-472.5K | $-0.04 | — |
| Q2 2025 | $0.00 | NaN% | $-1.7M | $-1.0M | $-0.09 | — |
| Q1 2025 | $0.00 | NaN% | $-1.3M | $-6.1M | $-2.15 | — |
| Q4 2024 | $0.00 | NaN% | $-1.2M | $-1.5M | $-11.12 | — |
| FY 2024 | $0.00 | NaN% | $-19.3M | $-13.2M | $-107.35 | — |
| Q3 2024 | $0.00 | NaN% | $-4.5M | $-4.9M | $-36.21 | — |
| Q2 2024 | $0.00 | NaN% | $-8.5M | $-3.9M | $-33.84 | — |
| Q1 2024 | $0.00 | NaN% | $-5.2M | $-2.9M | $-28.13 | — |
| Q4 2023 | $0.00 | -Infinity% | $-7.2M | $-11.1M | $-121.15 | — |
| FY 2023 | $0.00 | NaN% | $-48.4M | $-48.9M | $-616.07 | — |